Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

benzinga.com/markets/earnings/25/07/46553159/quest-diagnostics-raises-outlook-but-warns-of-tariff-and-medicare-act-risks

Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.
However, the diagnostic test provider flagged potential headwinds from ongoing…

This story appeared on benzinga.com, 2025-07-22 17:10:48.
The Entire Business World on a Single Page. Free to Use →